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Abstract
This report describes a case of brain death (BD) evaluated by 99mTc-hexamethylpropylene amine oxime (HMPAO) single photon 
emission tomography/computed tomography (SPECT/CT). A 16-year-old boy with a history of rapid unexpected brain herniation 
due to pilocytic astrocytoma underwent 99mTc-HMPAO SPECT/CT for evaluation of brain death in the context of organ donation. 
Flow images demonstrated lack of blood flow to the brain, and delayed images showed absence of demonstrable radionuclide 
activity within the brain. SPECT/CT confirmed absence of tracer accumulation, and was deemed helpful for evaluation of the 
brain stem. 99mTc-HMPAO SPECT/CT is a valuable tool enabling imaging-based confirmation of BD.
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Background
Determination of brain death in children is a clinical diagno-
sis based on the absence of neurologic function with a known 
irreversible cause of coma [1]. Ancillary studies (such as elec-
troencephalogram and radionuclide cerebral blood flow studies) 
are not required to establish the diagnosis of brain death, but 
may be used to assist in establishing the diagnosis, particularly 
when components of the clinical examination or apnea testing 
cannot be completed safely due to the underlying medical 
condition of the patient, when there is uncertainty about the 
results of the neurologic examination, if a medication effect may 
be present, or to reduce the observation period before organ 
donation [1–4]. Brain perfusion scintigraphy using 99mTc-HMPAO 
represents a well-studied method for diagnosing brain death [5]. 
Brain perfusion imaging has a very high sensitivity while the 
specificity (absent cerebral perfusion with clinical confirmation 
of brain death) is virtually 100% [5–9].
Case report
A 16-year-old boy experienced abrupt onset of headaches, 
dizziness, nausea and finally loss of consciousness. Computed 
tomography demonstrated acute hydrocephalus occlusus, general-
ized brain edema, and consecutive brain herniation due to a large 
infratentorial tumor. The patient underwent craniectomy and tumor 
resection, and histopathologic evaluation later revealed pilocytic 
astrocytoma. Intraoperative assessment showed extensive brain 
damage and the intracranial pressure was at 50 mmHg. Before 
organ donation, 99mTc-hexamethylpropylene amine oxime (HMPAO) 
single photon emission tomography/computed tomography 
(SPECT/CT) was performed as an ancillary test for evaluation of 
brain death (Figure 1). Flow images demonstrated lack of blood 
flow to the brain, and the sagittal sinus could not be noted. De-
layed planar images in anterior and right lateral views showed 
absence of demonstrable radionuclide activity within the brain. 
The maximum-intensity-projection SPECT image showed foci of 
tracer uptake corresponding to the sphenoidal sinuses, and to 
the parotid and lacrimal glands. SPECT/CT confirmed absence of 
tracer accumulation, consistent with brain death, and was deemed 
particularly helpful for evaluation of the brain stem and differentiation 
of brain stem activity from sinus uptake.
Discussion
SPECT has been suggested to be helpful for reducing the effect 
of overlying scalp activity and for evaluating the posterior fossa in 
the diagnostic work-up of brain death [8, 9]. In recent years, the 
introduction of SPECT/CT has improved diagnostic algorithms in 
many areas of nuclear medicine. The morphological information 
from CT has been shown to provide useful anatomical details, to 
improve the reliability of imaging-based diagnoses, to provide 
data for attenuation correction and — more recently — to provide 
absolute quantification of uptake in SPECT studies [10, 11]. Like in 
this case, SPECT/CT in the context of brain death providing detailed 
anatomical information could potentially help differentiate brain 
stem perfusion from other causes of tracer uptake, e.g., adjacent 
sinus activity, with great reliability. This is the first case in the litera-
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ture demonstrating that 99mTc-HMPAO SPECT/CT is a valuable tool 
enabling imaging-based confirmation of brain death.
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Figure 1A–E. Flow images in the anterior view (A) demonstrated lack of blood flow 
to the brain, and the sagittal sinus could not be noted. Delayed planar images  
in anterior and right lateral views (B) showed absence of demonstrable radionuclide 
activity within the brain. The maximum-intensity-projection SPECT image showed 
foci of tracer uptake corresponding to the sphenoidal sinuses, and to the parotid 
and lacrimal glands (C). SPECT/CT at the level of the brain stem (D) and lacrimal 
glands (E) confirmed absence of tracer accumulation, consistent with brain 
death, and was deemed particularly helpful for evaluation of the brain stem and 
differentiation of brain stem activity from sinus uptake (arrow)
